Innovative Biotechnologies is categorized under Nonclassified Establishments in Grand Island, NY .
Innovative Biotechnologies was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Nonclassified Establishments business, which does work in the BOTH market, and is classified as a Nonclassified Establishments, under code number 9999900 by the NAICS.
If you are seeking more information, feel free to contact Richard Montagna, Chief Executive Officer at the company’s single location by writing to 2680 Grand Island Boulevard # 1, Grand Island, New York NY 14072 or by phoning (716) 773-4232. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Innovative Biotechnologies |
Contact Person: | Richard Montagna, Chief Executive Officer |
Address: | 2680 Grand Island Boulevard # 1, Grand Island, New York 14072 |
Phone Number: | (716) 773-4232 |
Annual Revenue (USD): | Unknown |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B & B2C |
Business Category: | Nonclassified Establishments |
SIC Code: | 9999 |
NAICS Code: | 9999900 |
Share This Business: |
Innovative Biotechnologies was started in 0 to provide professional Nonclassified Establishments under the SIC code 9999 and NAICS code 9999900. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Richard Montagna, Chief Executive Officer for inquiries that concern Innovative Biotechnologies by calling the company number (716) 773-4232, as your correspondence is most welcome. Additionally, the physical location of the single location of Innovative Biotechnologies can be found at the coordinates 43.03418,-78.97468 as well as the street address 2680 Grand Island Boulevard # 1 in Grand Island, New York 14072.
For its online presence, you may visit Innovative Biotechnologies’s website at and engage with its social media outlets through on Twitter and on Facebook.